Definium Therapeutics Announces $500 Million Public Offering
Definium Therapeutics (NASDAQ:DFTX) announced a public offering of up to $500 million in common shares and pre-funded warrants, with an option for underwriters to purchase additional shares worth up to $75 million. The move is expected to raise significant capital for the company.
